Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other Non-Current Assets (2023 - 2025)

Bioadaptives' Other Non-Current Assets history spans 3 years, with the latest figure at $2500.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Assets changed 0.0% year-over-year to $2500.0; the TTM value through Sep 2025 reached $2500.0, changed 0.0%, while the annual FY2024 figure was $2500.0, 0.0% changed from the prior year.
  • Other Non-Current Assets for Q3 2025 was $2500.0 at Bioadaptives, roughly flat from $2500.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2500.0 in Q4 2023 and bottomed at $2500.0 in Q4 2023.
  • The 3-year median for Other Non-Current Assets is $2500.0 (2023), against an average of $2500.0.
  • The largest YoY upside for Other Non-Current Assets was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Other Non-Current Assets shows it stood at $2500.0 in 2023, then changed by 0.0% to $2500.0 in 2024, then changed by 0.0% to $2500.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Other Non-Current Assets are $2500.0 (Q3 2025), $2500.0 (Q2 2025), and $2500.0 (Q1 2025).